Graphnet Health has been selected by Jersey’s Family Nursing & Home Care (FNHC) to provide the island’s first large-scale remote monitoring service, in a landmark project funded through the Impact Jersey CareTech Challenge programme and delivered by Digital Jersey. The contract will see FNHC use Gr
Sequana Medical, a specialist in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, has announced the successful completion of the first commercial implantation of the alfapump System in the United States. This is a key milestone in Sequana Medical’s U.S comme
Developer of transformative implants Xeltis has announced that it has secured nearly 50m EUR of new financing, consisting of up to 37.5m EUR from the EIB, supported under the European Commission’s Invest EU programme, and 10m EUR from existing investors, including EQT, investing from its LSP Health
Medtronic has announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The Hugo RAS system’s clearance brings a versatile robotic-assisted platform to U.S. surgeons and health systems seeking to expand s
Altera Digital Health has announced a new partnership with PC PAL to enhance paediatric care within its Sunrise EPR system, with Maidstone and Tunbridge Wells NHS Trust becoming the first NHS trust to implement advanced growth charting as part of this innovation. Through the integration of GrowthXP,
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers flags a new study highlighting the benefits of AI in stroke analysis. Stroke patients in England are receiving life-saving treatment more tha
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers highlights funding for work to develop a new mobile quantum brain scanner. The UK Ministry of Defence has announced funding for the world’s f
Diagnostics company Neuro Event Labs Oy (NEL) has announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for clinical use of its Nelli Seizure Monitoring System in the hospital setting. Nelli, recognised by the FDA as a Breakthrough Device, is the world’s first non-c
NHS Supply Chain is supporting the NHS to treat cancer patients quicker with the supply of 28 ‘cutting edge’ new linear accelerator (LINAC) radiotherapy systems in 2025/26 to NHS cancer centres across the country. The rollout of the new technology is backed by centralised government funding provided
Martin Murphy, Principal Consultant at 42 Technology explains what impact the FDA’s upcoming new regulation will have on drug delivery device developers. The regulatory world of medical devices is undergoing one of the most significant transformations in nearly three decades. The long-standing Quali
Editor Oli Johnson speaks to HiArc President Nate Doemling about the role the company plays in product development for life sciences companies, offering a tactical guide on avoiding common design and regulatory missteps. Earlier this year, HiArc rebranded from its previous name, KMC Systems, as the
Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, and mjn-neuro, a start-up that designs, manufactures and markets medical devices, have announced the upcoming launch of EPISERAS, a digital health solution desig
